Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Oestradiol
OESTRADIOL IMPLANTS(R) 1 OESTRADIOL IMPLANTS(R) _Oestradiol hemihydrate_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Oestradiol Implants. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Oestradiol Implants against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS INFORMATION WITH THE PACK. You may wish to read it again. WHAT OESTRADIOL IMPLANTS ARE USED FOR Oestradiol is one of the female hormones your body makes. During and after menopause oestrogen production by your body decreases. If the ovaries are removed surgically before menopause, the decrease in oestrogen production occurs very abruptly. This decrease may lead to hot flushes, bone loss, vaginal irritation, recurrent urinary tract infections and urinary incontinence. Oestradiol Implants can be prescribed for the loss of oestrogen production by your body. After insertion under the skin, oestradiol is slowly released and absorbed into the blood, thus exerting a uniform action over several months. It substitutes the natural oestrogen production (oestrogen replacement therapy). Oestradiol Implants have no effect on alertness and concentration as far as is known. A doctor's prescription is required to obtain this medicine. BEFORE YOU HAVE OESTRADIOL IMPLANTS INSERTED _WHEN YOU MUST NOT TAKE IT_ DO NOT HAVE OESTRADIOL IMPLANTS INSERTED IF: * you are pregnant or think you may be pregnant * you are breastfeeding * you have high blood pressure * you have or if it is suspected that you have an oestrogen-dependent tumour, such as cancer of the lining of the womb or breast cancer * you have abnormal vaginal bleeding, which ha Read the complete document
1 PRODUCT INFORMATION OESTRADIOL IMPLANTS (I) NAME OF THE MEDICINAL PRODUCT Oestradiol Implants ® (consisting of oestradiol anhydrous 20 mg, 50 mg or 100 mg) C 18 H 24 O 2 _ _272.39 CAS No. 50-28-2 (anhydrous) (II) DESCRIPTION Each implant contains 20, 50 or 100 mg of 17 β-oestradiol. Oestradiol implants contain no excipients. The implants are white to pale brown, opaque or translucent cylinders, secured by two white wool plugs, in a sealed glass tube with a white snap-ring. The 20 mg implants are approximately 2.15 mm in diameter and 6 mm long. The 50 mg and 100 mg implants are approximately 4.5 mm in diameter and 3 mm and 6 mm long respectively. (III) PHARMACOLOGY PHARMACODYNAMIC PROPERTIES Oestradiol therapy is effective in the treatment of oestrogen deficiency symptoms following natural or surgical menopause in women. Like other oestrogens, it has a stimulating effect on the atrophic tissues of the female urogenital tract. Oestradiol implants change the lipoprotein profile: LDL-C, VLDL-C, total cholesterol and triglycerides may decrease, whereas HDL-C may increase. Oestradiol causes proliferative changes in the endometrium, but hyperplasia can be prevented by addition of a progestagen. With Oestradiol Implants a suppression of both FSH and LH has been observed. Oestradiol Implants have few, if any, adverse effects on liver function, protein metabolism, carbohydrate metabolism, blood pressure and blood clotting factors. SHBG-binding capacity may increase. PHARMACOKINETIC PROPERTIES After insertion of an implant into the subcutaneous fat the oestradiol plasma level reaches its maximum in a few days and shows a slow and gradual decline for the life of the implant. As with other oestrogens and progestagens, there are large inter-individual differences in hormone levels, but intra-individual variability appears to be small. 2 After repeated implantation, oestradiol levels reach high Read the complete document